Financing Research Of A Biotechnology Co.,Ltd.

Under the background of economic development,expanding market scale and increasing support from national science and technology development,biotechnology industry has gradually developed and realized large-scale industrialization in China.A number of new industries,such as biomedicine industry,bio-agriculture industry,biochemical industry and bio-energy industry,are constantly developing in the market.In this context,more and more small-scale biological enterprises are gradually developing in the market,moving towards the direction of biotechnology innovation research and industry.With their relatively low cost and relatively high efficiency,they have achieved remarkable development in the market.However,it should be noted that small and medium-sized biotechnology enterprises are always troubled by financing problems in their development.Under the influence of the characteristics of high investment,high risk and long cycle in biotechnology industry,combined with industry and market factors,small and medium-sized biotechnology enterprises have obvious problems of small scale,decentralization and significant inadequacy of investment.The financing problems of small and medium-sized biotechnology pharmaceutical enterprises need to be solved urgently.Yes.Under this background,this paper takes Anhui Lymga Biotechnology Co.,Ltd.as the research object,on the basis of relevant theoretical research,analyses the company's development environment,past financing strategy and current situation,points out the shortcomings and reasons of the company's financing strategy,and puts forward some pertinent suggestions on this basis.It is found that there are some problems in Anhui Limjia Biotechnology Co.,Ltd.such as unclear financing plan,unscientific financing structure,insufficient bank credit and insufficient technological innovation.The root causes of these problems lie in the lack of managers' awareness,insufficient personnel quality,imperfect credit mechanism and single financing mode.They should be from short-term financing,long-term financing and supply chain.Financing and the new third board to the main board of IPO financing aspects to optimize,while with a clear development strategy,technical team innovation,internal system reform and lean management measures to promote the sustainable and stable development of enterprises.